SHELLY CHANDLER: Open Payments
NPI 1629055736 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $515
Food & beverage: $473Education: $43
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Amgen Inc. | 3 | $71 |
| Mannkind Corporation | 2 | $59 |
| ABBVIE INC. | 2 | $54 |
| Lilly USA, LLC | 3 | $54 |
| Sequel Med Tech, LLC | 2 | $51 |
| Dexcom, Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $26 |
| BETA BIONICS, INC. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: JARDIANCE, EVENITY, AFREZZA, MOUNJARO, TWIIST, Dexcom G6 Transmitter, REZDIFFRA, iLet Bionic Pancreas.
Industry payments across CT — which companies pay providers there.
